198 related articles for article (PubMed ID: 20508527)
1. Cardiac sarcoidosis mimicking non-ST-elevation myocardial infarction.
Uijlings R; Balt JC; Boom P; Wever E
J Cardiovasc Med (Hagerstown); 2012 Apr; 13(4):277-80. PubMed ID: 20508527
[No Abstract] [Full Text] [Related]
2. Left ventricular asynchrony in early isolated cardiac sarcoidosis.
Nagai T; Arakawa J; Fujikawa A; Kastushika S
Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):40. PubMed ID: 26578651
[No Abstract] [Full Text] [Related]
3. Early diagnosis of cardiac sarcoidosis using magnetic resonance imaging.
Osman F; Foundon A; Leyva P; Pitt M; Murray RG
Int J Cardiol; 2008 Mar; 125(1):e4-5. PubMed ID: 17337076
[TBL] [Abstract][Full Text] [Related]
4. Predictors of cardiac sarcoidosis using commonly available cardiac studies.
Freeman AM; Curran-Everett D; Weinberger HD; Fenster BE; Buckner JK; Gottschall EB; Sauer WH; Maier LA; Hamzeh NY
Am J Cardiol; 2013 Jul; 112(2):280-5. PubMed ID: 23602692
[TBL] [Abstract][Full Text] [Related]
5. Extra-pulmonary manifestations of sarcoidosis.
Vardhanabhuti V; Venkatanarasimha N; Bhatnagar G; Maviki M; Iyengar S; Adams WM; Suresh P
Clin Radiol; 2012 Mar; 67(3):263-76. PubMed ID: 22094184
[TBL] [Abstract][Full Text] [Related]
6. [Active cardiac sarcoidosis: Diagnosis and adjustment of therapy with FDG PET/CT].
Philippe L; Casset-Senon D; Lorette G; Diot P; Cosnay P
Presse Med; 2015 Jun; 44(6 Pt 1):690-2. PubMed ID: 25534464
[No Abstract] [Full Text] [Related]
7. The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis.
Matoh F; Satoh H; Shiraki K; Odagiri K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Cardiol; 2008 Jun; 51(3):179-88. PubMed ID: 18522793
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
[TBL] [Abstract][Full Text] [Related]
9. Cardiac imaging in myocardial sarcoidosis and other cardiomyopathies.
Sharma S
Curr Opin Pulm Med; 2009 Sep; 15(5):507-12. PubMed ID: 19542892
[TBL] [Abstract][Full Text] [Related]
10. Pleomorphism during Ventricular Tachycardia: A Distinguishing Feature between Cardiac Sarcoidosis and Idiopathic VT.
Panda S; Kaur D; Lalukota K; Sundar G; Pavri BB; Narasimhan C
Pacing Clin Electrophysiol; 2015 Jun; 38(6):694-9. PubMed ID: 25754130
[TBL] [Abstract][Full Text] [Related]
11. Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis.
Kruse MJ; Kovell L; Kasper EK; Pomper MG; Moller DR; Solnes L; Chen ES; Schindler TH
JACC Cardiovasc Imaging; 2017 Feb; 10(2):157-167. PubMed ID: 28109920
[TBL] [Abstract][Full Text] [Related]
12. Imaging of sarcoidosis: self-assessment module.
Prabhakar HB; Rabinowitz CB; Chew FS
AJR Am J Roentgenol; 2008 Mar; 190(3 Suppl):S7-10. PubMed ID: 18321847
[TBL] [Abstract][Full Text] [Related]
13. Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques.
Pandya C; Brunken RC; Tchou P; Schoenhagen P; Culver DA
Eur Respir J; 2007 Feb; 29(2):418-22. PubMed ID: 17264327
[TBL] [Abstract][Full Text] [Related]
14. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
Skali H; Schulman AR; Dorbala S
Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
[TBL] [Abstract][Full Text] [Related]
15. [Conduction defects as the presenting feature of sarcoidosis or observed during the course of the disease: regression with corticoid steroid therapy].
Berhouet M; Casset-Senon D; Machet MC; Lesire V; Farrokhi-Moshai T; Fauchier L; Charniot JC; Babuty D; Cosnay P
Arch Mal Coeur Vaiss; 2003 Jun; 96(6):677-82. PubMed ID: 12868351
[TBL] [Abstract][Full Text] [Related]
16. Sarcoidosis.
Bergot E; Paparel P; Zalcman G
N Engl J Med; 2008 Mar; 358(13):1404; author reply 1404-5. PubMed ID: 18376441
[No Abstract] [Full Text] [Related]
17. Pseudotumoral renal sarcoid: MRI, PET, and MDCT appearance with pathologic correlation.
Heldmann M; Behm W; Reddy MP; Bozeman C; Welman G; Abreo F; Minagar A
AJR Am J Roentgenol; 2005 Sep; 185(3):697-9. PubMed ID: 16120920
[No Abstract] [Full Text] [Related]
18. Cardiac sarcoidosis: the complementary role of 18F-FDG PET and MRI.
Van Schandevyl S; Waterschoot R; De Vos N; Devos D; Goethals I
J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):335-336. PubMed ID: 31809284
[No Abstract] [Full Text] [Related]
19. Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis.
Ishimaru S; Tsujino I; Sakaue S; Oyama N; Takei T; Tsukamoto E; Tamaki N; Nishimura M
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):234-5. PubMed ID: 16315788
[No Abstract] [Full Text] [Related]
20. Cardiac sarcoidosis with visually normal wall motion: role of cardiac MRI, FDG PET, and strain echocardiography.
Saeed IM; Coggins T; Main ML; Bateman TM
Eur Heart J Cardiovasc Imaging; 2015 Nov; 16(11):1275. PubMed ID: 26206467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
